ID   CNL_CLINE               Reviewed;         149 AA.
AC   B2ZRS9;
DT   16-MAR-2016, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 1.
DT   03-AUG-2022, entry version 46.
DE   RecName: Full=Ricin B-like lectin {ECO:0000303|PubMed:19100814};
DE   AltName: Full=Clitocybe nebularis lectin {ECO:0000303|PubMed:19100814};
DE            Short=CNL {ECO:0000303|PubMed:19100814};
OS   Clitocybe nebularis (Clouded agaric) (Lepista nebularis).
OC   Eukaryota; Fungi; Dikarya; Basidiomycota; Agaricomycotina; Agaricomycetes;
OC   Agaricomycetidae; Agaricales; Tricholomataceae; Clitocybe.
OX   NCBI_TaxID=117024 {ECO:0000312|EMBL:ACD47153.1};
RN   [1] {ECO:0000312|EMBL:ACD47153.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], PROTEIN SEQUENCE OF 3-32; 41-70;
RP   74-105; 109-114; 117-136 AND 142-149, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBSTRATE SPECIFICITY, SUBUNIT, PTM, MASS SPECTROMETRY, AND
RP   ACETYLATION AT SER-2.
RC   STRAIN=Vrh2004 {ECO:0000312|EMBL:ACD47153.1};
RC   TISSUE=Fruiting body {ECO:0000312|EMBL:ACD47153.1};
RX   PubMed=19100814; DOI=10.1016/j.bbagen.2008.11.006;
RA   Pohleven J., Obermajer N., Sabotic J., Anzlovar S., Sepcic K., Kos J.,
RA   Kralj B., Strukelj B., Brzin J.;
RT   "Purification, characterization and cloning of a ricin B-like lectin from
RT   mushroom Clitocybe nebularis with antiproliferative activity against human
RT   leukemic T cells.";
RL   Biochim. Biophys. Acta 1790:173-181(2009).
RN   [2] {ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD, ECO:0007744|PDB:3NBE}
RP   PARTIAL PROTEIN SEQUENCE, X-RAY CRYSTALLOGRAPHY (1.01 ANGSTROMS) OF 2-149
RP   IN COMPLEX WITH LACTOSE AND LDN, FUNCTION, SUBSTRATE SPECIFICITY, SUBUNIT,
RP   DOMAIN, MASS SPECTROMETRY, CIRCULAR DICHROISM ANALYSIS, AND MUTAGENESIS OF
RP   ASP-21; LEU-55 AND ASN-111.
RC   TISSUE=Fruiting body {ECO:0000269|PubMed:22298779};
RX   PubMed=22298779; DOI=10.1074/jbc.m111.317263;
RA   Pohleven J., Renko M., Magister S., Smith D.F., Kunzler M., Strukelj B.,
RA   Turk D., Kos J., Sabotic J.;
RT   "Bivalent carbohydrate binding is required for biological activity of
RT   Clitocybe nebularis lectin (CNL), the N,N'-diacetyllactosediamine
RT   (GalNAcbeta1-4GlcNAc, LacdiNAc)-specific lectin from basidiomycete C.
RT   nebularis.";
RL   J. Biol. Chem. 287:10602-10612(2012).
RN   [3]
RP   FUNCTION, MASS SPECTROMETRY, AND BIOTECHNOLOGY.
RX   PubMed=21556921; DOI=10.1007/s00253-011-3236-0;
RA   Pohleven J., Brzin J., Vrabec L., Leonardi A., Cokl A., Strukelj B.,
RA   Kos J., Sabotic J.;
RT   "Basidiomycete Clitocybe nebularis is rich in lectins with insecticidal
RT   activities.";
RL   Appl. Microbiol. Biotechnol. 91:1141-1148(2011).
RN   [4]
RP   FUNCTION.
RX   PubMed=22044067; DOI=10.1111/j.1365-2567.2011.03500.x;
RA   Svajger U., Pohleven J., Kos J., Strukelj B., Jeras M.;
RT   "CNL, a ricin B-like lectin from mushroom Clitocybe nebularis, induces
RT   maturation and activation of dendritic cells via the toll-like receptor 4
RT   pathway.";
RL   Immunology 134:409-418(2011).
RN   [5]
RP   FUNCTION.
RX   PubMed=21486374; DOI=10.1111/j.1365-294x.2011.05093.x;
RA   Bleuler-Martinez S., Butschi A., Garbani M., Waelti M.A., Wohlschlager T.,
RA   Potthoff E., Sabotic J., Pohleven J., Luethy P., Hengartner M.O., Aebi M.,
RA   Kuenzler M.;
RT   "A lectin-mediated resistance of higher fungi against predators and
RT   parasites.";
RL   Mol. Ecol. 20:3056-3070(2011).
CC   -!- FUNCTION: Lectin specific for terminal, non-reducing N-
CC       acetylgalactosamine (Gal-NAc)-containing carbohydrates including N,N'-
CC       diacetyllactosediamine/LDN (GalNAcbeta1-4GlcNAc, LacdiNAc). Specific
CC       also for carbohydrates containing N-acetylglucosamine (-GlcNAc) or N-
CC       acetyllactosamine (-Galbeta1-4GlcNAc) at the reducing end. Agglutinates
CC       human blood group A, AB, B and O erythrocytes with a strong preference
CC       for group A. Agglutinates bovine erythrocytes with a very low
CC       specificity (PubMed:19100814, PubMed:22298779). Binds carbohydrates
CC       bivalently, which is required for its biological activity
CC       (PubMed:22298779). Exhibits insecticidal activity against the fruit fly
CC       D.melanogaster, mosquito A.aegypti, and amoebozoa A.castellanii. Has
CC       anti-nutritional activity against Colorado potato beetle
CC       L.decemlineata, and against worm C.elegans (PubMed:21556921,
CC       PubMed:21486374). Has antiproliferative activity against human leukemic
CC       T-cells (PubMed:19100814). Has an immunostimulatory effect on human
CC       antigen-presenting dendritic cells, which are subsequently able to
CC       induce efficient T-cell immune responses (PubMed:22044067).
CC       {ECO:0000269|PubMed:19100814, ECO:0000269|PubMed:21486374,
CC       ECO:0000269|PubMed:21556921, ECO:0000269|PubMed:22044067,
CC       ECO:0000269|PubMed:22298779}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6-6.5. Retains more than 70% of the maximum
CC         agglutinating activity over the pH range 5-9.
CC         {ECO:0000269|PubMed:19100814};
CC       Temperature dependence:
CC         Unchanged hemagglutinating activity after 30 minutes incubation at
CC         temperatures up to 50 degrees Celsius, then at higher temperatures
CC         activity decreases. 14% of the initial activity is retained even
CC         after heating at 100 degrees Celsius. {ECO:0000269|PubMed:19100814};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19100814,
CC       ECO:0000269|PubMed:22298779}.
CC   -!- DOMAIN: Contains a single ricin B lectin domain with a characteristic
CC       beta-trefoil fold consisting of three repeated subdomains each
CC       containing a more or less conserved QXW motif.
CC       {ECO:0000305|PubMed:22298779}.
CC   -!- PTM: The N-terminus is blocked. {ECO:0000269|PubMed:19100814}.
CC   -!- MASS SPECTROMETRY: Mass=15903.5; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:19100814};
CC   -!- MASS SPECTROMETRY: Mass=15992; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:22298779};
CC   -!- MASS SPECTROMETRY: Mass=15903; Method=Electrospray;
CC       Evidence={ECO:0000269|PubMed:21556921};
CC   -!- BIOTECHNOLOGY: Potential for use as natural insecticide.
CC       {ECO:0000303|PubMed:21556921}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU682006; ACD47153.1; -; Genomic_DNA.
DR   EMBL; FJ477895; ACK56062.1; -; mRNA.
DR   PDB; 3NBC; X-ray; 1.01 A; A/B=2-149.
DR   PDB; 3NBD; X-ray; 1.15 A; A/B=2-149.
DR   PDB; 3NBE; X-ray; 1.86 A; A/B=2-149.
DR   PDBsum; 3NBC; -.
DR   PDBsum; 3NBD; -.
DR   PDBsum; 3NBE; -.
DR   AlphaFoldDB; B2ZRS9; -.
DR   SMR; B2ZRS9; -.
DR   UniLectin; B2ZRS9; -.
DR   iPTMnet; B2ZRS9; -.
DR   EvolutionaryTrace; B2ZRS9; -.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF14200; RicinB_lectin_2; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Lectin.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:19100814"
FT   CHAIN           2..149
FT                   /note="Ricin B-like lectin"
FT                   /id="PRO_0000435793"
FT   REGION          110..112
FT                   /note="Involved in dimerization"
FT                   /evidence="ECO:0000269|PubMed:22298779,
FT                   ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD"
FT   BINDING         21
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:22298779,
FT                   ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD"
FT   BINDING         24
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:22298779,
FT                   ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD"
FT   BINDING         39
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:22298779,
FT                   ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD"
FT   BINDING         47
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:22298779,
FT                   ECO:0007744|PDB:3NBC, ECO:0007744|PDB:3NBD"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000269|PubMed:19100814"
FT   MUTAGEN         21
FT                   /note="D->R: No sugar-binding, hemagglutination of human
FT                   group A erythrocytes nor toxicity to Jurkat leukemia
FT                   cells."
FT                   /evidence="ECO:0000269|PubMed:22298779"
FT   MUTAGEN         55
FT                   /note="L->R: No effect on sugar-binding, but loss of
FT                   dimerization, hemagglutination of human group A
FT                   erythrocytes and toxicity to Jurkat leukemia cells; when
FT                   associated with D-111."
FT                   /evidence="ECO:0000269|PubMed:22298779"
FT   MUTAGEN         55
FT                   /note="L->W: No effect on sugar-binding, but loss of
FT                   dimerization, hemagglutination of human group A
FT                   erythrocytes and toxicity to Jurkat leukemia cells; when
FT                   associated with D-111."
FT                   /evidence="ECO:0000269|PubMed:22298779"
FT   MUTAGEN         111
FT                   /note="N->D: No effect on sugar-binding, hemagglutination
FT                   of human group A erythrocytes and dimerization, but reduced
FT                   toxicity to Jurkat leukemia cells. No effect on
FT                   sugar-binding, but loss of dimerization, hemagglutination
FT                   of human group A erythrocytes and toxicity to Jurkat
FT                   leukemia cells; when associated with R-55. No effect on
FT                   sugar-binding, but loss of dimerization, hemagglutination
FT                   of human group A erythrocytes and toxicity to Jurkat
FT                   leukemia cells; when associated with W-55."
FT                   /evidence="ECO:0000269|PubMed:22298779"
FT   CONFLICT        31
FT                   /note="T -> V (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32
FT                   /note="L -> I (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..14
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          19..22
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   HELIX           23..25
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          31..36
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   TURN            41..43
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          50..54
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          58..68
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          71..74
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   HELIX           75..77
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          84..90
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          94..98
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          112..117
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          128..131
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:3NBC"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:3NBC"
SQ   SEQUENCE   149 AA;  15993 MW;  28E71535B79818CB CRC64;
     MSITPGTYNI TNVAYTNRLI DLTGSNPAEN TLIIGHHLNK TPSGYGNQQW TLVQLPHTTI
     YTMQAVNPQS YVRVRDDNLV DGAALVGSQQ PTPVSIESAG NSGQFRIKIP NLGLALTLPS
     DANSTPIVLG EVDETSTNQL WAFESVSAV
//
